» Articles » PMID: 7075034

Postnatal Development of Tubular Phosphate Reabsorption

Overview
Journal Clin Nephrol
Specialty Nephrology
Date 1982 Apr 1
PMID 7075034
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

In 51 infants (0.5-12 months) and 143 children (1-15 years), the postnatal development of renal phosphate handling could be studied by short term clearance investigations. The infants demonstrated significantly higher values of plasma phosphate (Pp), urinary phosphate excretion and endogenous phosphate clearance than the children. Net tubular phosphate reabsorption (Tp) was low infancy due to low glomerular filtration rate (CIn). The fractional phosphate reabsorption (Tp/CIn), however, was significantly higher in infancy than in childhood. There was a close correlation between fractional phosphate reabsorption and plasma phosphate for both children and infants. When the regression lines of Pp to Tp/CIn were analyzed separately for children and infants, a parallel shift was recognized, which means that at each level of Tp/CIn infants had higher plasma phosphate concentrations than children. Evaluation of available data suggests that the shift was very probably related to low CIn in the young infants which may lead to further retention of phosphate.

Citing Articles

Unusual variants implicate uncommon genetic mechanisms for X-linked hypophosphatemic rickets.

Alzoebie L, Li D, Wang X, Weber D, Levine M JBMR Plus. 2024; 9(1):ziae152.

PMID: 39677929 PMC: 11646311. DOI: 10.1093/jbmrpl/ziae152.


Transient secondary pseudo-hypoaldosteronism in infants with urinary tract infections: systematic literature review.

Betti C, Lavagno C, Bianchetti M, Kottanattu L, Lava S, Schera F Eur J Pediatr. 2024; 183(10):4205-4214.

PMID: 38985174 PMC: 11413108. DOI: 10.1007/s00431-024-05676-3.


An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

Zhu Z, Bo-Ran Ho B, Chen A, Amrhein J, Apetrei A, Carpenter T Kidney Int. 2024; 105(5):1058-1076.

PMID: 38364990 PMC: 11106756. DOI: 10.1016/j.kint.2024.01.031.


X-linked hypophosphatemia, fibroblast growth factor 23 signaling, and craniosynostosis.

Grimbly C, Graf D, Ward L, Alexander R Exp Biol Med (Maywood). 2024; 248(22):2175-2182.

PMID: 38230523 PMC: 10800125. DOI: 10.1177/15353702231222023.


Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets.

Baroncelli G, Sessa M, Pelosini C, Bertelloni S, Michelucci A, Toschi B J Endocrinol Invest. 2023; 47(4):873-882.

PMID: 37991698 PMC: 10965647. DOI: 10.1007/s40618-023-02202-4.